Drug-Coated Stents Face Further Scrutiny

Law360, New York (November 30, 2006, 12:00 AM EST) -- With a Food and Drug Administration advisory panel set to examine drug-coated stents at an upcoming meeting, a report has shown that the devices increase the risk of life-threatening blood clots in patients with coronary artery disease by four or five times that of bare-metal stents.

The analysis, which was released Wednesday by the Cleveland Clinic, added to the growing body of evidence that drug-coated stents potentially trigger more heart attacks than their older and cheaper bare-metal counterparts.

“Our analysis found there is a small, but...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.